Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Other Non Operating Income (2016 - 2025)

Jaguar Health (JAGX) has disclosed Other Non Operating Income for 11 consecutive years, with -$2.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Non Operating Income fell 1442.86% to -$2.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.3 million, a 288.21% decrease, with the full-year FY2024 number at $1.2 million, down 66.32% from a year prior.
  • Other Non Operating Income was -$2.3 million for Q3 2025 at Jaguar Health, down from $322000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $3.7 million in Q3 2023 to a low of -$2.3 million in Q3 2025.
  • A 5-year average of $195117.6 and a median of $26000.0 in 2023 define the central range for Other Non Operating Income.
  • Biggest YoY gain for Other Non Operating Income was 10475.0% in 2024; the steepest drop was 2903.85% in 2024.
  • Jaguar Health's Other Non Operating Income stood at -$763000.0 in 2021, then skyrocketed by 511.14% to $3.1 million in 2022, then tumbled by 100.45% to -$14000.0 in 2023, then skyrocketed by 4107.14% to $561000.0 in 2024, then crashed by 502.14% to -$2.3 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Other Non Operating Income are -$2.3 million (Q3 2025), $322000.0 (Q2 2025), and $112000.0 (Q1 2025).